biomarkers() a dataset of curated biomarkers relevant to Alzheimer's
disease (AD) and related neurodegenerative conditions. Each row corresponds
to a defined biomarker, including both directly measured biomarkers and
derived indicators such as ratios. Variables include identification of the
biomarker (bmk_id and bmk_name), reference(s) to underpinning analyte(s)
(analyte_ids), and classification details.
Value
A tibble with the following columns:
bmk_idShort identifier for the biomarker (e.g.,
"ab42","ptau181_ab42_ratio").bmk_nameHuman-readable label (e.g.,
"Aβ42 / Aβ40","Amyloid PET").bmk_categoryTop-level role:
"core","non-specific", or"co-pathology".bmk_classStage or use-tier within category (e.g.,
"core 1","core 2").bmk_subclassBiological process aligned with the ATNISV framework (e.g.,
"A","T1","N").bmk_modalityMeasurement domain:
"fluid"or"imaging".bmk_typeWhether the biomarker is
"original"(directly measured) or"derived"(e.g., ratios).analyte_idsList of one or more analyte IDs underpinning the biomarker definition.
bmk_descShort description of what the biomarker measures or represents.
Details
Biomarkers are organized into a structured, three-tier classification system that reflects their biological role, pathogenic target, and stage in the disease process:
bmk_category: the highest level of classification, reflecting the biomarker's overall diagnostic role. Categories include:"core": biomarkers of AD neuropathologic change (ADNPC), essential for diagnosis and staging;"non-specific": biomarkers relevant to AD pathophysiology but not specific to AD;"co-pathology": markers that capture common comorbid pathologies frequently co-occurring with AD.
bmk_class: a subdivision of the category level, used to distinguish between earlier- and later-appearing markers in the course of disease progression.For example:
"core 1"includes A and T1 markers that become abnormal early and support diagnosis;"core 2"includes T2 markers that become abnormal later and support disease staging.
bmk_subclass: identifies the specific biological process or proteinopathy the biomarker represents, aligned with the updated ATNISV framework:"A": amyloid-beta proteinopathy;"T1": soluble tau fragments (e.g., p-tau181, p-tau217, p-tau231);"T2": tau aggregates (e.g., tau PET, MTBR-tau243);"N": neurodegeneration;"I": inflammation and immune activation;"S": synucleinopathy;"V": vascular brain injury.
In contrast, the bmk_modality field is not part of the classification
hierarchy but denotes the technical measurement domain—either "fluid"
(e.g., CSF, plasma) or "imaging" (e.g., PET, MRI). This
distinction is critical because the same biological process (e.g., amyloid
pathology) may be captured through multiple modalities, which differ in their
temporal resolution, biological specificity, and clinical application. The
updated criteria explicitly reject the assumption of equivalence between
fluid and imaging biomarkers, hence the need to treat modality separately.
Examples
biomarkers()
#> # A tibble: 23 × 9
#> bmk_id bmk_name bmk_category bmk_class bmk_subclass bmk_modality bmk_type
#> <chr> <chr> <chr> <chr> <chr> <chr> <chr>
#> 1 ab40 Aβ40 core core 1 A fluid original
#> 2 ab42 Aβ42 core core 1 A fluid original
#> 3 ab42_ab40… Aβ42 / … core core 1 A fluid derived
#> 4 amyloid_p… Amyloid… core core 1 A imaging original
#> 5 t_tau Total t… core core 1 T1 fluid original
#> 6 ptau217 p-tau217 core core 1 T1 fluid original
#> 7 ptau181 p-tau181 core core 1 T1 fluid original
#> 8 ptau231 p-tau231 core core 1 T1 fluid original
#> 9 ptau181_a… p-tau18… core core 1 T1 fluid derived
#> 10 ptau217_n… p-tau21… core core 1 T1 fluid derived
#> # ℹ 13 more rows
#> # ℹ 2 more variables: analyte_ids <list>, bmk_desc <chr>